ORCID

We notice you are using a browser that our site does not support. Some features on this site may not work correctly. We recommend that you upgrade to a supported browser.

Activities

Collapse all

Targeting complement anaphylatoxin C3a receptor to break immunotherapy resistance in colorectal cancer

2024-07-01 to 2028-06-30 | Grant

American Cancer Society (Atlanta, US)

DOI: 10.53354/ACS.RSG-24-1255025-01-IBCD.pc.gr.193733

GRANT_NUMBER:

RSG-24-1255025-01-IBCD

Show more detail

Source:

check_circle

American Cancer Society - ProposalCentral

How many people are using ORCID?

https://orcid.org/0000-0001-9998-5716

Activities

Funding (1)

Targeting complement anaphylatoxin C3a receptor to break immunotherapy resistance in colorectal cancer

https://orcid.org/0000-0001-9998-5716

Personal information

Activities

Funding (1)

Targeting complement anaphylatoxin C3a receptor to break immunotherapy resistance in colorectal cancer